Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Isbell

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
The Annals of Thoracic Surgery|February 5, 2024
The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung CancerElizabeth G Dunne, Cameron N Fick, James M Isbell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 14, 2020
The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung AdenocarcinomaRaul Caso, Francisco Sanchez-Vega, Kay See Tan, et al.
Annals of Surgery|February 2, 2023
Waiting to Operate: The Risk of Salvage EsophagectomyThomas Boerner, Caitlin Harrington, Kay See Tan, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 23, 2023
Superior sulcus non-small cell lung cancers (Pancoast tumors): Current outcomes after multidisciplinary managementKaitlin McLaughlin, Kay See Tan, Joe Dycoco, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2022
Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancerHarry B Lengel, Junting Zheng, Kay See Tan, et al.
British Journal of Anaesthesia|June 20, 2021
Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinomaJames G Connolly, Kay See Tan, Brooke Mastrogiacomo, et al.
Annals of Surgery|August 13, 2021
Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal AdenocarcinomaRebecca A Carr, Meier Hsu, Caitlin A Harrington, et al.
British Journal of Anaesthesia|July 17, 2021
Intraoperative ketorolac may interact with patient-specific tumour genomics to modify recurrence risk in lung adenocarcinoma: an exploratory analysisJames G Connolly, Joseph R Scarpa, Hersh V Gupta, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 11, 2021
Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung AdenocarcinomaDaniel J Gross, Navin K Chintala, Raj G Vaghjiani, et al.
Chest|July 8, 2023
The Thoracic Research Evaluation and Treatment 2.0 Model: A Lung Cancer Prediction Model for Indeterminate Nodules Referred for Specialist EvaluationCaroline M Godfrey, Maren E Shipe, Valerie F Welty, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
The Annals of Thoracic Surgery|February 5, 2024
The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung CancerElizabeth G Dunne, Cameron N Fick, James M Isbell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 14, 2020
The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung AdenocarcinomaRaul Caso, Francisco Sanchez-Vega, Kay See Tan, et al.
Annals of Surgery|February 2, 2023
Waiting to Operate: The Risk of Salvage EsophagectomyThomas Boerner, Caitlin Harrington, Kay See Tan, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 23, 2023
Superior sulcus non-small cell lung cancers (Pancoast tumors): Current outcomes after multidisciplinary managementKaitlin McLaughlin, Kay See Tan, Joe Dycoco, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2022
Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancerHarry B Lengel, Junting Zheng, Kay See Tan, et al.
British Journal of Anaesthesia|June 20, 2021
Intraoperative opioid exposure, tumour genomic alterations, and survival differences in people with lung adenocarcinomaJames G Connolly, Kay See Tan, Brooke Mastrogiacomo, et al.
Annals of Surgery|August 13, 2021
Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal AdenocarcinomaRebecca A Carr, Meier Hsu, Caitlin A Harrington, et al.
British Journal of Anaesthesia|July 17, 2021
Intraoperative ketorolac may interact with patient-specific tumour genomics to modify recurrence risk in lung adenocarcinoma: an exploratory analysisJames G Connolly, Joseph R Scarpa, Hersh V Gupta, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 11, 2021
Tumor and Tumor-Associated Macrophage Programmed Death-Ligand 1 Expression Is Associated With Adjuvant Chemotherapy Benefit in Lung AdenocarcinomaDaniel J Gross, Navin K Chintala, Raj G Vaghjiani, et al.
Chest|July 8, 2023
The Thoracic Research Evaluation and Treatment 2.0 Model: A Lung Cancer Prediction Model for Indeterminate Nodules Referred for Specialist EvaluationCaroline M Godfrey, Maren E Shipe, Valerie F Welty, et al.
Pageof 13